10/17/2024 3:54 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
|
10/04/2024 3:18 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
08/13/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
06/04/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 9:16 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 1:19 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 8:04 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 3:43 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 9:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024 9:31 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 3:45 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024 9:24 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024 9:29 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024 9:43 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:57 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 3:15 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024 9:38 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 10:03 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 9:32 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024 3:49 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 9:12 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 2:44 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024 9:54 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 10:57 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024 5:01 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
04/02/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024 12:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 10:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 10:37 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 10:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 5:47 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 10:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:12 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 10:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |